Evidence map›Paper›PMID 41168902›Full record

ArticlePilot and feasibility studies2025

Investigation of an integrated standardised pain assessment and management tool in addition to usual care versus usual care alone in oncology outpatient clinics for adults with pain: the CAPTURE cluster randomised pilot trial protocol. ISRCRN86926298.

Olivia C Robinson, Elaine G Boland, Florence Day, Marie Fallon, Amanda Farrin, Kate Flemming, Sean Girvan, Sue M Hartup, Adam Hurlow, David Meads and 7 more

Abstract read
In one paragraph

Article in Pilot and feasibility studies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Olivia C RobinsonLeeds Institute of Health Sciences, University of Leeds, Worsley Building, Clarendon Way, Leeds, LS2 9NL, UK.
Elaine G BolandPalliative Medicine, Hull University Teaching Hospitals NHS Trust, Hull, HU15 5JQ, UK.
Florence DayLeeds Institute of ClinicalTrials Research, University of Leeds, Worsley Building, Clarendon Way, Leeds, LS2 9NL, UK.
Marie FallonCancer Research UK Edinburgh Centre, MRC Institute of Genetics & Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XR, UK.
Amanda FarrinLeeds Institute of ClinicalTrials Research, University of Leeds, Worsley Building, Clarendon Way, Leeds, LS2 9NL, UK.
Kate FlemmingDepartment of Health Sciences, The University of York, York, YO10 5DD, UK.
Sean GirvanLeeds Institute of ClinicalTrials Research, University of Leeds, Worsley Building, Clarendon Way, Leeds, LS2 9NL, UK.
Sue M HartupSt James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, LS9 7TF, UK.
Adam HurlowSt James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, LS9 7TF, UK.
David MeadsLeeds Institute of Health Sciences, University of Leeds, Worsley Building, Clarendon Way, Leeds, LS2 9NL, UK.
Catriona R MaylandSchool of Medicine and Population Health, University of Sheffield, Sheffield, S10 2SJ, UK.
John L O'DwyerLeeds Institute of Health Sciences, University of Leeds, Worsley Building, Clarendon Way, Leeds, LS2 9NL, UK.
Simon PiniLeeds Institute of Health Sciences, University of Leeds, Worsley Building, Clarendon Way, Leeds, LS2 9NL, UK.
Suzanne H RichardsLeeds Institute of Health Sciences, University of Leeds, Worsley Building, Clarendon Way, Leeds, LS2 9NL, UK.
Daniel SwinsonSt James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, LS9 7TF, UK.
Michelle Collinson *Leeds Institute of ClinicalTrials Research, University of Leeds, Worsley Building, Clarendon Way, Leeds, LS2 9NL, UK.
Matthew R Mulvey *Leeds Institute of Health Sciences, University of Leeds, Worsley Building, Clarendon Way, Leeds, LS2 9NL, UK. M.R.Mulvey@leeds.ac.uk.ORCID http://orcid.org/0000-0002-6357-3848

Funding

Yorkshire Cancer Research RA/2019/R1/001
6 · The paper itself

Abstract

backgroundEach year in the UK approximately 367,000 people are diagnosed with cancer of whom half will experience moderate to severe chronic pain and a third are undertreated for their pain. Most people with cancer are cared for at oncology outpatient services where there are no standardised approaches for managing pain. As a result, cancer patients are at risk of receiving inadequate care for pain. There is a need for a standardised approach to pain management within oncology outpatient services. METHODS/

designThe aim of this pilot trial is to establish the feasibility of conducting a multi-centre clustered-randomised trial of an integrated standardised pain assessment and management programme integrated within routine care at oncology outpatient services in the United Kingdom National Health Service (NHS). We will conduct a two-arm pilot cluster randomised trial with nested process evaluation to evaluate the feasibility and acceptability of trial processes, establish fidelity of intervention implementation, estimate variability in outcomes and feasibility of future economic evaluation. Twelve outpatient services (clusters) from at least two NHS tertiary oncology referral centres (sites), in the North of England will be randomised (1:1) to deliver a pain management programme plus usual care or usual care alone and will recruit a total sample of 180 participants. Adults attending a participating outpatient service who self-report a score of ≥ 3 on the 0-10 Numerical Rating Scale (NRS) for worst pain in the past 72 h in any part of their body, and will be available for 1-week follow-up will be eligible. Participant self-reported questionnaires will be collected at baseline, 1-week, 1-month, and 2-months with medical record review at 1-month and 2-months. Progression to a future trial will be based on pre-defined criteria associated with eligibility and consent rates, follow-up and intervention delivery and acceptability. DISCUSSION: Little research has described optimal ways to implement a standardised pain assessment and management programme into oncology outpatient services. The strengths of the pilot trial are its sample size, number of clusters, and planned evaluation of trial processes and intervention fidelity to provide robust trial evidence to fully inform a future definitive phase III multi-centre cluster randomised trial within the UK NHS.

trial registrationThe CAPTURE pilot trial is registered on the ISRCTN registry (86,926,298).

Indexed as

CancerCluster trialOutpatient settingPainPilot

Identifiers

PMID41168902
PMCPMC12574234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.